The present invention provides pyrazole derivativesrepresented by the general formula:(see formula I)wherein R1 represents H, an optionally substituted C1-6 alkyl,etc. ； one of Q and T represents a group selected from the following:(see formula II, III, IV, V, VI)and the other represents -Z-Ar wherein Z represents -O-, -S-,etc.； Ar represents an optionally substituted C6-10 aryl, etc.；R represents an optionally substituted C3-8 cycloalkyl, anoptionally substituted C6-10 aryl, etc., pharmaceuticallyacceptable salts thereof, and prodrugs thereof, which exhibitan excellent inhibitory activity in human sodium/glucosecotransporter (SGLT) and are useful as agents for the prevention,inhibition of progression or treatment of a disease associatedwith the excess uptake of at least a kind of carbohydrates selectedfrom glucose, fructose and mannose (diabetes, postprandialhyperglycemia, impaired glucose tolerance, diabeticcomplications, etc.), and pharmaceutical compositionscontaining the same, medicinal uses thereof and intermediatesfor production therefor.
